Condition: Soft Tissue Sarcoma · Clear Cell Sarcoma · Epithelioid Sarcoma · Sponsor: Institut Claudius Regaud
This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of patients (100 cases in total) will be identified in all centers through the GSF/GETO clinical databases already setted up (including the clinical base Conticabase).
This description comes directly from the study's public registry record.
Thibaud VALENTIN · +33 (0)5 31 15 51 70 · Valentin.Thibaud@iuct-oncopole.fr
Frédéric CHIBON · +33 (0)5 82 74 17 65 · frederic.chibon@inserm.fr
Always discuss trial participation with your own doctor first.
| Chu Besancon - Site Jean Minjoz | Besançon, France | Recruiting |
| Institut Bergonié | Bordeaux, France | Recruiting |
| Centre Jean Perrin | Clermont-Ferrand, France | Recruiting |
| Centre Georges François Leclerc | Dijon, France | Not Yet Recruiting |
| Centre Oscar Lambret | Lille, France | Recruiting |
| Chu Dupuytren | Limoges, France | Recruiting |
| Centre Leon Berard | Lyon, France | Recruiting |
| Institut Paoli-Calmettes | Marseille, France | Withdrawn |
| Chu de Marseille - Hopital de La Timone | Marseille, France | Recruiting |
| Centre Antoine Lacassagne | Nice, France | Recruiting |
| Hôpital Cochin - Site Port-Royal | Paris, France | Recruiting |
| Institut Curie | Paris, France | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03967834